Cargando…
Fructooligosaccharide raftilose reduces the mycophenolate mofetil-induced complications: Hematological and biochemical alterations
Mycophenolate mofetil (MMF) is a selective inhibitor of Inosine-5′-monophosphate dehydrogenase. Gastrointestinal (GI) disturbances in immature ones are reported for MMF-induced compilations, which in the case of occurrence dose reduction is required. Thus, in the present study, the fructooligosaccha...
Autores principales: | Cheraghi, Hadi, Khaki, Zohreh, Malekinejad, Hassan, Sasani, Farhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Urmia University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769338/ https://www.ncbi.nlm.nih.gov/pubmed/26973768 |
Ejemplares similares
-
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013) -
Silymarin attenuates mycophenolate mofetil-induced duodenal disorders in rats
por: Malekinejad, Hassan, et al.
Publicado: (2014) -
Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis
por: Malekinejad, H., et al.
Publicado: (2012) -
Mycophenolate Mofetil Use in Severe Myocarditis Complicating Systemic Lupus
por: Allaoui, Abire, et al.
Publicado: (2022) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)